#nexium

[eosinophil-hate-blog]

[mindblowingscience]

Popular heartburn drugs linked to higher death risk

Risk increases the longer the drugs are used

Popular heartburn drugs called proton pump inhibitors (PPIs) have been linked to a variety of health problems, including serious kidney damage, bone fractures and dementia. Now, a new study from Washington University School of Medicine in St. Louis shows that longtime use of the drugs also is associated with an increased risk of death.

Millions of U.S. residents take proton pump inhibitors which are widely prescribed to treat heartburn, ulcers and other gastrointestinal problems. The drugs also are available over the counter under brand names that include Prevacid, Prilosec and Nexium.

For the study, the researchers examined medical records of some 275,000 users of PPIs and nearly 75,000 people who took another class of drugs - known as H2 blockers - to reduce stomach acid. The research is published online July 3 in the journal BMJ Open.

"No matter how we sliced and diced the data from this large data set, we saw the same thing: There's an increased risk of death among PPI users," said senior author Ziyad Al-Aly, MD, an assistant professor of medicine. "For example, when we compared patients taking H2 blockers with those taking PPIs for one to two years, we found those on PPIs had a 50 percent increased risk of dying over the next five years. People have the idea that PPIs are very safe because they are readily available, but there are real risks to taking these drugs, particularly for long periods of time."

Continue Reading.

[eosinophil-hate-blog]

[online-druggist]

Nexium Control is a branded version of esomeprazole drug, available without a prescription for heartburn treatment and acid reflux in adults over 18 years of age. Nexium Control is available as gastro-resistant tablets and capsules, both containing 20mg of esomeprazole

[sesliprospektus]

Nexium Tablet Nedir, Niçin Kullanılır, Nasıl Kullanılır, Yan Etkileri Ne...

[thenighthawk]

Locations - The Five Kingdoms | The Five Worlds

We live in cities you'll never see on-screen Not very pretty, but we sure know how to run things Livin' in ruins of a palace within my dreams And you know we're on each other's team

[myphamgiasi]

Nexium 24hr, thuốc nexium mỹ, viên uống điều trị trào ngược dạ dày, thuốc trị chứng ợ chua, ợ nóng thực quản, review thuốc nexium 24h, thuốc nexium có tốt không, thuốc tiêu hóa nexium, thuốc đầy bụng khó tiêu

Thuốc Nexium 24HR

Nếu bạn bị ợ chua, ợ nóng chỉ cần một tiếng nấc nhẹ là sau đó một cảm giác rát ở ngực và cổ họng sẽ diễn ra. Các nhà nghiên cứu ước tính rằng khoảng 7% người Mỹ bị chứng ợ nóng hàng ngày và khoảng 14-20% bị trào ngược dạ dày. Trào ngược là hiện tượng axit trong dạ dày bị đẩy lên thực quản, đây là ống dẫn thức ăn và đồ uống từ miệng đi đến dạ dày. Trào ngược dạ dày thực quản (GERD), một tình trạng mãn tính với nhiều nguyên nhân tiềm ẩn. Đôi khi vị chua ở phía sau miệng lại là nguồn gốc của các triệu chứng khác gồm ho, hen suyễn, mòn răng và viêm xoang. GERD là chứng rối loạn tiêu hóa phổ biến nhất hiện nay, nó có thể được kích hoạt bởi thức ăn bạn ăn, đặc biệt là thức ăn cay, béo hoặc có tính axit.

[siglerprescriptiondrugcards]

Esomeprazole

Common Brand Names: Nexium

Therapeutic Class: Proton Pump Inhibitor

Common Injectable Dosage Forms:

Powder for Reconstitution: 20 mg and 40 mg vials

Dosage Ranges:

For the treatment of gastroesophageal reflux disease (GERD): 20 mg or 40 mg once daily for no more than 10 days. Change to oral therapy as soon as possible.

No dosage adjustment necessary in elderly or renal impairment.

Dosage should not exceed 20 mg/day in severe hepatic impairment.

Administration and Stability: May be administered by slow injection (no less than 3 minutes) or infusion (10-30 minutes). Flush line with NS, LR, or D5W. Reconstitute vial with 5 mL NS, LR, or D5W, then further dilute to final volume of 50 mL for infusion. Solution for infusion prepared with D5W should be used within 6 hours. Refrigeration not necessary. Protect from light.

Pharmacology/Pharmacokinetics: Esomeprazole suppresses gastric acid secretion by inhibition of the H+/K+-ATPase in the gastric parietal cells. Volume of distribution is approximately 16 L. Half-life elimination and time to peak are both approximately 1.5 hours.

Drug and Lab Interactions: Esomeprazole may increase levels of carbamazepine, HMG-CoA reductase inhibitors, methotrexate, and CYP2C19 substrates (benzodiazepines, etc.). Phenytoin and rifampin may decrease levels of esomeprazole. Levels of atazanavir, indinavir, iron salts, itraconazole, and ketoconazole may be decreased by esomeprazole.

Contraindications/Precautions: Contraindicated in patients with hypersensitivity to esomeprazole or any substituted benzimidazoles (lansoprazole, pantoprazole, etc.). Severe liver dysfunction may require dosage reduction, use caution. Atrophic gastritis has been experienced with long-term esomeprazole therapy. Pregnancy Category B.

Monitoring Parameters: Liver function tests

Adverse Effects: Headache, dizziness, itching, flatulence, nausea, diarrhea, and xerostomia have been reported. Symptoms of overdose include confusion, drowsiness, blurred vision, tachycardia, nausea, and sweating.

Common Clinical Applications: Useful for the short-term (10 days or less) treatment of gastroesophageal reflux disease (GERD) when oral therapy is not possible.